Target Name: MIR1912
NCBI ID: G100302144
Review Report on MIR1912 Target / Biomarker Content of Review Report on MIR1912 Target / Biomarker
MIR1912
Other Name(s): hsa-mir-1912 | MIRN1912 | mir-1912 | microRNA 1912 | hsa-miR-1912-5p | MicroRNA 1912 | Hsa-mir-1912 | hsa-miR-1912-3p

MIR1912: A Drug Target / Disease Biomarker

MIR1912, also known as interleukin-18 (IL-18), is a protein that is expressed in a variety of tissues throughout the body, including the lungs, heart, kidneys, and intestines. It is a cytokine that is involved in the regulation of inflammation and immune responses.

One of the things that makes MIR1912 an attractive drug target is its ability to stimulate the production of pro-inflammatory cytokines. These cytokines, such as IL-1尾 and IL-6, are important for the recruitment of immune cells to the site of inflammation and for the regulation of inflammatory responses. MIR1912 has been shown to be able to induce the production of these cytokines in a variety of cell types, including immune cells and epithelial cells.

Another potential mechanism by which MIR1912 may be a drug target is its role in the regulation of cellular processes that are important for the development of cancer. For example, MIR1912 has been shown to be able to promote the migration of cancer cells to new sites of infection or to inhibit the production of anti-cancer drugs.

In addition to its potential as a drug target, MIR1912 is also a potential biomarker for a variety of diseases. For example, MIR1912 has been shown to be elevated in the blood of individuals with a variety of diseases, including cancer, autoimmune disorders, and chronic obstructive pulmonary disease (COPD). Additionally, MIR1912 has been shown to be involved in the regulation of cellular processes that are important for the development and progression of these diseases, which may make it an attractive target for diagnostic tests.

Overall, MIR1912 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its mechanisms of action and to determine its potential as a therapeutic agent.

Protein Name: MicroRNA 1912

The "MIR1912 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1912 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B | MIR20A | MIR20B | MIR21 | MIR210 | MIR210HG | MIR211 | MIR2110 | MIR2113 | MIR2114 | MIR2115 | MIR2116 | MIR2117 | MIR212 | MIR214 | MIR215 | MIR216A | MIR216B | MIR217 | MIR217HG | MIR218-1 | MIR218-2 | MIR219A1 | MIR219A2 | MIR219B | MIR22 | MIR221 | MIR222 | MIR223 | MIR224 | MIR2276 | MIR2277 | MIR2278 | MIR22HG | MIR2355 | MIR2392 | MIR23A | MIR23AHG | MIR23B | MIR23C | MIR24-1 | MIR24-2 | MIR2467 | MIR25 | MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B | MIR28 | MIR2861 | MIR2909 | MIR296 | MIR297